Therapeutic Asset Ratings
4,361 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
PREDNISONE TABLETS
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
National Cancer Institute (NCI)
P3
BB
(65)
(+)-VINCRISTINE
T-Cell Adult Acute Lymphocytic Leukemia
National Cancer Institute (NCI)
P3
BB
(65)
(+)-VINCRISTINE
Neuroendocrine Tumor
National Cancer Institute (NCI)
P3
BB
(65)
(+)-VINCRISTINE
Ovarian Mucinous Cystadenocarcinoma
National Cancer Institute (NCI)
P3
BB
(65)
Azacitidine
Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11
National Cancer Institute (NCI)
P2
BB
(65)
Cediranib
Duct Cell Adenocarcinoma of the Pancreas
National Cancer Institute (NCI)
P2
BB
(65)
Cediranib
Metastatic Prostate Carcinoma
National Cancer Institute (NCI)
P2
BB
(65)
Cediranib
Recurrent Childhood Medulloblastoma
National Cancer Institute (NCI)
P2
BB
(65)
Cediranib
Recurrent Malignant Solid Neoplasm
National Cancer Institute (NCI)
P2
BB
(65)
Cediranib
Refractory Anemia
National Cancer Institute (NCI)
P2
BB
(65)
Cediranib
Refractory Anemia With Ringed Sideroblasts
National Cancer Institute (NCI)
P2
BB
(65)
Cediranib
Refractory Malignant Neoplasm
National Cancer Institute (NCI)
P2
BB
(65)
Cediranib
Triple-Negative Breast Carcinoma
National Cancer Institute (NCI)
P2
BB
(65)
Cediranib
Unresectable Solid Neoplasm
National Cancer Institute (NCI)
P2
BB
(65)
Cyclophosphamide
Mesothelioma
National Cancer Institute (NCI)
P2
BB
(65)
Cytosin-Arabinosid
Central Nervous System Neoplasm
National Cancer Institute (NCI)
P2
BB
(65)
Durvalumab
Fallopian Tube Carcinoma
National Cancer Institute (NCI)
P2
BB
(65)
FILGRASTIM
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
National Cancer Institute (NCI)
P2
BB
(65)
FILGRASTIM
B-Cell Adult Acute Lymphocytic Leukemia
National Cancer Institute (NCI)
P2
BB
(65)
Glofitamab
High Grade B-Cell Lymphoma
National Cancer Institute (NCI)
P2
BB
(65)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Plasmablastic Lymphoma
National Cancer Institute (NCI)
P2
BB
(65)
Irinotecan
Fallopian Tube Adenocarcinoma
National Cancer Institute (NCI)
P2
BB
(65)
Monomethyl Fumarate
Hematologic Malignancies
National Cancer Institute (NCI)
P2
BB
(65)
Monomethyl Fumarate
Immune System Diseases
National Cancer Institute (NCI)
P2
BB
(65)
Palbociclib
Malignant Pancreatic Neoplasm
National Cancer Institute (NCI)
P2
BB
(65)
Showing 376 to 400 of 4,361 assets
Previous
Page 16 of 175
Next